StonvexLoading…
StonvexStonvexStonvexCore line items from PNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.15B | $1.04B | $4.18B | $3.16B | $2.13B |
Operating Income | Not available | $210.00M | $857.50M | $652.50M | $420.80M |
Net Income | Not available | $172.40M | $653.80M | $487.70M | $303.40M |
EPS (Diluted) | $1.49 | $1.05 | $3.96 | $2.94 | $1.83 |
Total Assets | Not available | $7.07B | $6.87B | $6.76B | $6.48B |
Total Liabilities | Not available | $3.26B | $3.00B | $2.98B | $2.81B |
Cash & Equivalents | Not available | $67.70M | $101.60M | $128.40M | $143.00M |
Free Cash Flow OCF − CapEx | Not available | $-85.90M | $746.00M | $718.90M | $540.00M |
Shares Outstanding | Not available | 163.70M | 165.50M | 165.70M | 166.00M |